✦ LIBER ✦

Reduced glutathione and Parkinson's disease

✍ Scribed by Gian Pietro Sechi

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 175 KB
Volume: 25
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.23383

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reply: Intravenous glutathione in Parkin

Reply: Intravenous glutathione in Parkinson's disease

✍ Robert A. Hauser; Kelly E. Lyons 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB 👁 1 views

We appreciate the careful reading of our manuscript by Okun and colleagues. 1 However, their letter contains a number of inaccuracies that require correction. We clearly state

Glutathion s-transferase (class μ) pheno

Glutathion s-transferase (class μ) phenotype in Parkinson's disease

✍ F. Tison; C. Coutelle; P. Henry; A. Cassaigne 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

tribution in PD was 50% GSTp+ (males 53%, females 48%) and 50% GSTp-(males 47%, females 52%). These results were not statistically different from that of the control group. Thus, absence of GSTp is not significantly associated with PD. However, we consider it useful to know not only which detoxifyi

Reduced brain glutamate in patients with

Reduced brain glutamate in patients with Parkinson's disease

✍ H. Randall Griffith; Ozioma C. Okonkwo; Timothy O'Brien; Jan A. den Hollander 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

Bradykinesia, muscle weakness and reduce

Bradykinesia, muscle weakness and reduced muscle power in Parkinson's disease

✍ Natalie E. Allen; Colleen G. Canning; Catherine Sherrington; Victor S.C. Fung 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

## Abstract Muscle power (force × velocity) could clarify the relationship between weakness and bradykinesia in Parkinson's disease (PD). The aims of this study were to determine if patients with PD were weaker and/or less powerful in their leg extensor muscles than a neurologically normal control

Is pathological gambling in Parkinson's

Is pathological gambling in Parkinson's disease reduced by amantadine?

✍ Jee-Young Lee; Han- Joon Kim; Beom S. Jeon 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB

Nigral glutathione deficiency is not spe

Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease

✍ Paul S. Fitzmaurice; Lee Ang; Mark Guttman; Ali H. Rajput; Yoshiaki Furukawa; St 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

## Abstract The consistent findings of decreased levels of the major antioxidant glutathione in substantia nigra of patients with idiopathic Parkinson's disease (PD) has provided most of the basis for the oxidative stress hypothesis of the etiology of PD. To establish whether a nigral glutathione d